Form 4: Alkermes Director David Angelo Daglio Jr. Reports Share Transactions
SEC Form 4 Filing
Director David Angelo Daglio Jr. reports acquisition and disposal of Alkermes plc ordinary shares and restricted stock units.
Summary
- On June 29, 2024, David Angelo Daglio Jr., a director of Alkermes plc, reported transactions involving the company's ordinary shares and restricted stock units.
- Daglio acquired 6,104 ordinary shares through the vesting of restricted stock units.
- He also disposed of 1,465 ordinary shares to cover tax obligations related to the vesting of the restricted stock units at a price of $24.1 per share.
- Following these transactions, Daglio directly owns 27,780 ordinary shares and indirectly owns 80,000 ordinary shares through The David A Daglio Jr Trust.
- The restricted stock unit award is fully vested.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transactions are routine and related to compensation and tax obligations. There is no indication of significant positive or negative sentiment.
Positives
- The vesting of restricted stock units indicates a positive performance milestone for Daglio.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their transactions in company stock. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Comparing Daglio's transactions to those of other directors in similar pharmaceutical companies would require analyzing their Form 4 filings.
- Generally, the vesting of restricted stock units is a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.
- The sale of shares to cover tax obligations is also a standard practice.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/21/2017 | Date of establishment of The David A Daglio Jr Trust U/A. |
| 06/29/2024 | Date of transactions involving ordinary shares and restricted stock units. |
| 07/01/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.